Muscle-derived IL-6 can inhibit the production of inflammatory cytokines such as TNF-α and IL-1β, while promoting secretion of anti-inflammatory cytokines like interleukin-10 (IL-10) (88), thereby improving inflammatory profile in patients with sarcopenic obesity. This evidence concerns the gene IL6 and obesity disorder.